Multiple Sclerosis Clinical Trial

Psychometric Validation of Cognitive Endpoints

Summary

The study will entail cognitive assessment of a single cohort of patients with Multiple Sclerosis. Each subject will be assessed twice, approximately 45 days apart. There will be no intervention or control group. Each participant will have a caregiver capable of responding to a brief report of observations regarding neuropsychological skills and abilities in the patient.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 to 65 years old (inclusive).
History of Relapsing-Remitting or Secondary Progressive Multiple Sclerosis
Physically able to see the testing materials and complete the tests
Have a family member or caregiver who is capable of consent and willing to complete the MSNQ-Informant questionnaire.

Exclusion Criteria:

A history of treated or untreated severe mental illness or diagnosis of major depression prior to MS onset.
Untreated major depression or untreated anxiety disorder.
History of Attention Deficit/Hyperactivity Disorder, Developmental Learning - Disorder including Mental Retardation.
History of traumatic brain injury with intracranial bleed, stroke, Alzheimer's disease, Parkinson's disease, Motor Coordination Disorder or other neurologic illness. I understand that if the Investigator believes this would interfere with successful completion of the protocol, I will be excluded.
A clinically significant relapse within the past 2 months. I have had a serious infection (e.g., pneumonia, septicemia) within the 2 month.
History of drug or alcohol abuse (as defined by the Investigator) within 1 year prior to Study Day 1.
Active bacterial or viral infection.
Use of marijuana within 2 months prior to Study Day 1or at any time during the study
Alcohol consumption within 24 hours of either test session.
Unable to comply with study requirements.
Expected survival time of less than 3 months.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT01335633

Recruitment Status:

Completed

Sponsor:

Kessler Foundation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 4 Locations for this study

See Locations Near You

Holy Name Hospital Multiple Sclerosis Center
Teaneck New Jersey, 07666, United States
Kessler Foundation
West Orange New Jersey, 07052, United States
University at Buffalo
Buffalo New York, 14203, United States
Lauren S. Caruso
White Plains New York, 10604, United States

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

60

Study ID:

NCT01335633

Recruitment Status:

Completed

Sponsor:


Kessler Foundation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider